# pharmaceutical industry

China’s TCM Clean‑Up: Regulatory Clock Ticks on ‘Unknown’ Safety Claims

China’s National Medical Products Administration is enforcing a rule that will bar re‑registration of traditional patent medicines whose package inserts still state key safety items as “not yet clear.” The measure aims to eliminate low‑use and poorly documented approvals, compel firms to supply safety data, and accelerate consolidation in an industry long criticised for uneven evidence on safety and efficacy.